HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$13.84
Day range
$13.53 - $14.26
Year range
$4.09 - $17.15
Market cap
401.92M USD
Avg Volume
242.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.62M | 9.76% |
Operating expense | 29.87M | -26.26% |
Net income | -11.94M | 46.44% |
Net profit margin | -64.13 | 51.21% |
Earnings per share | -0.42 | 60.00% |
EBITDA | -10.11M | 55.39% |
Effective tax rate | -0.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 185.85M | -14.23% |
Total assets | 329.50M | -5.49% |
Total liabilities | 202.91M | -14.32% |
Total equity | 126.59M | — |
Shares outstanding | 28.75M | — |
Price to book | 3.15 | — |
Return on assets | -9.22% | — |
Return on capital | -9.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -11.94M | 46.44% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Headquarters
Website
Employees
120
